Table of Content




1. Executive Summary


2. Global Skin Cancer Diagnostics & Therapeutics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Skin Cancer Diagnostics & Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Skin Cancer Diagnostics & Therapeutics Market by Cancer Type
3.3.1: Melanoma
3.3.2: Non-melanoma

3.4: Global Skin Cancer Diagnostics & Therapeutics Market by Type
3.4.1: Diagnosis
3.4.2: Therapeutics
3.4.3: Others






4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Skin Cancer Diagnostics & Therapeutics Market by Region
4.2: North American Skin Cancer Diagnostics & Therapeutics Market
4.2.2: North American Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others


4.3: European Skin Cancer Diagnostics & Therapeutics Market
4.3.1: European Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
4.3.2: European Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others


4.4: APAC Skin Cancer Diagnostics & Therapeutics Market
4.4.1: APAC Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
4.4.2: APAC Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others


4.5: ROW Skin Cancer Diagnostics & Therapeutics Market
4.5.1: ROW Skin Cancer Diagnostics & Therapeutics Market by Cancer Type: Melanoma and Non-melanoma
4.5.2: ROW Skin Cancer Diagnostics & Therapeutics Market by Type: Diagnosis, Therapeutics, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Cancer Type
6.1.2: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Type

6.1.3: Growth Opportunities for the Global Skin Cancer Diagnostics & Therapeutics Market by Region

6.2: Emerging Trends in the Global Skin Cancer Diagnostics & Therapeutics Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Skin Cancer Diagnostics & Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Skin Cancer Diagnostics & Therapeutics Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: AB Science
7.2: Abbott Laboratories
7.3: Amgen
7.4: AstraZeneca
7.5: Bristol-Myers Squibb
7.6: Castle Biosciences
7.7: Daiichi Sankyo
7.8: DAMAE Medical
7.9: DermTech
7.10: F. Hoffmann-La Roche